Form D · Pharmaceuticals
CARDAX, INC.
Honolulu, HI · CIK 0001544238
Offering snapshot reported Sep 30, 2021 · SEC filing
- Reported sold
- $200K Offering amount: $500K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 16, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2021 | Initial | $200,000 | No comparison | 5 | SEC filing |
| May 19, 2017 | Amendment | $1,540,000 | $1,037,000vs May 20, 2016 | 50 | SEC filing |
| May 20, 2016 | Initial | $503,000 | No comparison | 10 | SEC filing |
| Nov 13, 2015 | Amendment | $1,591,222 | $466,222vs Jun 30, 2015 | 29 | SEC filing |
| Jun 30, 2015 | Amendment | $1,125,000 | $835,000vs Mar 12, 2015 | 21 | SEC filing |
| Mar 12, 2015 | Initial | $290,000 | No comparison | 4 | SEC filing |
| Feb 21, 2014 | Initial | $3,923,100 | No comparison | 62 | SEC filing |
| Jun 1, 2012 | Amendment | $33,000 | $0vs May 30, 2012 | 33 | SEC filing |
| May 30, 2012 | Initial | $33,000 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-415318
Convertible debt
Source: Form D, filed Sep 30, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George W. Bickerstaff Iii | Director |
| Nazneen D'silva | Director, Executive, Promoter |
| D?Silva D?Silva | Director, Executive, Promoter |
| Michele Galen | Director |
| Frank C. Herringer | Director |
| Tamar D. Howson | Director |
| Terence A. Kelly | Director |
| Nicholas Mitsakos | Director, Executive |
| John B. Russell | Executive |
| David M. Watumull | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2800 Woodlawn Drive Suite 129
Honolulu, HI, 96822
Honolulu, HI, 96822